Novel erythropoiesis stimulating protein -: NESP -: Darbepoetin alfa -: ARANESP® -: Hematopoietic -: Antianemic -: Oncolytic

被引：0

|

作者：

不详

机构：

来源：

DRUGS OF THE FUTURE | 2001年 / 26卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：304 / 305

页数：2

相关论文

共 50 条

[41] Identification of the long-acting erythropoiesis-stimulating agent darbepoetin alfa in human urine by liquid chromatography–tandem mass spectrometry
Masato Okano
Mitsuhiko Sato
Shinji Kageyama
Analytical and Bioanalytical Chemistry, 2014, 406 : 1317 - 1329
[42] Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact
Zoltán Kiss
Steven Elliott
Kinga Jedynasty
Vladimír Tesar
János Szegedi
European Journal of Clinical Pharmacology, 2010, 66 : 331 - 340
[43] Change in darbepoetin alfa administration schedule affects erythropoiesis-stimulating agent resistance in patients with chronic kidney disease receiving hemodialysis
Molina, Manuel
Jose Navarro, Maria
de Gracia, Carmen
Alvarez, Gracia
de Alarcon, Rosa
Angeles Garcia, Maria
RENAL FAILURE, 2008, 30 (08) : 778 - 783
[44] Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact
Kiss, Zoltan
Elliott, Steven
Jedynasty, Kinga
Tesar, Vladimir
Szegedi, Janos
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (04) : 331 - 340
[45] Novel erythropoiesis stimulating protein (NESP) has a longer serum half-life and greater in vivo biological activity than recombinant human erythropoietin (rHuEPO).
Egrie, JC
Dwyer, E
Lykos, M
Hitz, A
Browne, JK
BLOOD, 1997, 90 (10) : 243 - 243
[46] Hematologic outcomes and costs in epoetin alfa (EPO) and darbepoetin alfa (DARB) treated cancer patients with anemia: results of the Dosing and Outcomes Study of Erythropoiesis Stimulating Therapies (DOSE Registry).
Memisoglu, A
Peake, C
Vichare, R
McKenzie, RS
Howell, J
Piech, CT
PHARMACOTHERAPY, 2005, 25 (10): : 1469 - 1469
[47] Identification of the long-acting erythropoiesis-stimulating agent darbepoetin alfa in human urine by liquid chromatography-tandem mass spectrometry
Okano, Masato
Sato, Mitsuhiko
Kageyama, Shinji
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2014, 406 (05) : 1317 - 1329
[48] Capillary electrophoresis and matrix-assisted laser desorption/ionization-time of flight-mass spectrometry for analysis of the novel erythropoiesis-stimulating protein (NESP)
Sanz-Nebot, V
Benavente, F
Giménez, E
Barbosa, J
ELECTROPHORESIS, 2005, 26 (7-8) : 1451 - 1456
[49] Applications of darbepoietin-α, a novel erythropoiesis-stimulating protein, in oncology
Smith, R
CURRENT OPINION IN HEMATOLOGY, 2002, 9 (03) : 228 - 233
[50] Exercise performance in hypoxia after novel erythropoiesis stimulating protein treatment
Lundby, C
Damsgaard, R
SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 2006, 16 (01) : 35 - 40

← 1 2 3 4 5 →